Recent webcast addresses what organizations can do to prepare for the next revision of ICH E6.
Andy Studna, Senior Editor
Advertisement
Articles by Andy Studna, Senior Editor
EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.
Sujay Jadhav, global vice president, study start-up, Oracle Health Sciences, spoke with ACT on how study start-up has been impacted by the pandemic and what its future holds beyond COVID.
Jody Casey of Elligo Health Research gives insight into the issue of diversity in trials and what needs to be done to correct it.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
Rethinking Operational Models to Reduce Site Burden in 2026
3
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5